1. EP014/#408 Evaluation of NAPI2B expression in a well annotated longitudinal tissue series of ovarian serous carcinomas. (4th December 2022) Authors: Drapkin, Ronny; Jung, Euihye; Bradshaw, Chelsea; Demars, Leslie; Mosher, Rebecca Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material. (4th December 2022) Authors: Richardson, Debra; Barve, Minal; Saltos, Andreas; Papadopoulos, Kyriakos; Hays, John; Tolcher, Anthony; Ellard, Susan; Doroshow, Deborah; Mitchell, Paul; Zarwan, Corrine; Werner, Theresa; Anderson, Charles; Spira, Alex; Mileshkin, Linda; Bradshaw, Chelsea; Demars, Leslie; Mosher, Rebecca; Hamilto... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (4th December 2022) Authors: Richardson, Debra; Perez Fidalgo, Jose Alejandro; Gonzalez-Martin, Antonio; Oaknin, Ana; Hamilton, Erika; Hays, John; Pothuri, Bhavana; Papadopoulos, Kyriakos; Taylor, Sara; Huang, Marilyn; Lee, Yeh-Chen; Krivak, Thomas; Moreno-Garcia, Victor; Calvo, Emiliano; Randall, Leslie; Starks, David; Ross... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗